Like many antibiotics, Clostridium difficile colitis has been associated with its use.

Treatment of recurrent clostridium difficile colitis with vancomycin and Saccharomyces boulardii.

Clostridium difficile colitis.

Long term use of antibiotics leads to resistance and chances of developing opportunistic infections like clostridium difficile colitis.

Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG.

As the bacteria overgrow they release toxins that attack the lining of the intestines, causing a condition called Clostridium difficile colitis.

In particular, highly concentrated form, marketed as probiotic supplements for the treatment of Clostridium difficile colitis, can possibly cause fungemia in critically ill patients.

Other products in development are Tolevamer for Clostridium difficile colitis disease and Campath for Chronic lymphocytic leukemia.

Patients should be treated as soon as possible when the diagnosis of Clostridium difficile colitis (CDC) is made to avoid frank sepsis or bowel perforation.

A well-known subtype of infectious colitis is Clostridium difficile colitis, which is informally abbreviated as "c diff colitis".

Antibiotics also can cause Clostridium difficile colitis (also called C. difficile colitis), a swelling and irritation of the large intestine, or colon .

Other causes of bacteremia include dental procedures (occasionally including simple tooth brushing), herpes (including herpetic whitlow), urinary tract infections, peritonitis, Clostridium difficile colitis, intravenous drug use, and colorectal cancer.

In one study, a patient who received a diagnosis of Clostridium difficile colitis (CDC) on the basis of computed tomography (CT scan) had an 88% probability of testing positive on stool assay.

An infection of the intestines caused by Clostridium difficile bacteria (pseudomembranous enterocolitis).

Diarrhea associated with pseudomembranous enterocolitis, diarrhea caused by antibiotic treatment, or diarrhea caused by enterotoxin-producing bacteria.